Literature DB >> 26000738

Monoallelic loss of the imprinted gene Grb10 promotes tumor formation in irradiated Nf1+/- mice.

Rana Mroue1, Brian Huang1, Steve Braunstein1, Ari J Firestone2, Jean L Nakamura1.   

Abstract

Imprinted genes are expressed from only one parental allele and heterozygous loss involving the expressed allele is sufficient to produce complete loss of protein expression. Genetic alterations are common in tumorigenesis but the role of imprinted genes in this process is not well understood. In earlier work we mutagenized mice heterozygous for the Neurofibromatosis I tumor suppressor gene (NF1) to model radiotherapy-associated second malignant neoplasms that arise in irradiated NF1 patients. Expression analysis of tumor cell lines established from our mouse models identified Grb10 expression as widely absent. Grb10 is an imprinted gene and polymorphism analysis of cell lines and primary tumors demonstrates that the expressed allele is commonly lost in diverse Nf1 mutant tumors arising in our mouse models. We performed functional studies to test whether Grb10 restoration or loss alter fundamental features of the tumor growth. Restoring Grb10 in Nf1 mutant tumors decreases proliferation, decreases soft agar colony formation and downregulates Ras signaling. Conversely, Grb10 silencing in untransformed mouse embryo fibroblasts significantly increased cell proliferation and increased Ras-GTP levels. Expression of a constitutively activated MEK rescued tumor cells from Grb10-mediated reduction in colony formation. These studies reveal that Grb10 loss can occur during in vivo tumorigenesis, with a functional consequence in untransformed primary cells. In tumors, Grb10 loss independently promotes Ras pathway hyperactivation, which promotes hyperproliferation, an early feature of tumor development. In the context of a robust Nf1 mutant mouse model of cancer this work identifies a novel role for an imprinted gene in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26000738      PMCID: PMC4441450          DOI: 10.1371/journal.pgen.1005235

Source DB:  PubMed          Journal:  PLoS Genet        ISSN: 1553-7390            Impact factor:   5.917


  59 in total

1.  The BPS domain of Grb10 inhibits the catalytic activity of the insulin and IGF1 receptors.

Authors:  E G Stein; T A Gustafson; S R Hubbard
Journal:  FEBS Lett       Date:  2001-03-30       Impact factor: 4.124

Review 2.  Grb7 in intracellular signaling and its role in cell regulation.

Authors:  Tang-Long Shen; Jun-Lin Guan
Journal:  Front Biosci       Date:  2004-01-01

3.  Mitogenic roles of Gab1 and Grb10 as direct cellular partners in the regulation of MAP kinase signaling.

Authors:  Youping Deng; Manchao Zhang; Heimo Riedel
Journal:  J Cell Biochem       Date:  2008-12-01       Impact factor: 4.429

4.  Conserved methylation imprints in the human and mouse GRB10 genes with divergent allelic expression suggests differential reading of the same mark.

Authors:  Philippe Arnaud; David Monk; Megan Hitchins; Emma Gordon; Wendy Dean; Colin V Beechey; Jo Peters; William Craigen; Michael Preece; Philip Stanier; Gudrun E Moore; Gavin Kelsey
Journal:  Hum Mol Genet       Date:  2003-05-01       Impact factor: 6.150

5.  The cyclic AMP pathway is a sex-specific modifier of glioma risk in type I neurofibromatosis patients.

Authors:  Nicole M Warrington; Tao Sun; Jingqin Luo; Robert C McKinstry; Patricia C Parkin; Sara Ganzhorn; Debra Spoljaric; Anne C Albers; Amanda Merkelson; Douglas R Stewart; David A Stevenson; David Viskochil; Todd E Druley; Jason T Forys; Karlyne M Reilly; Michael J Fisher; Uri Tabori; Jeffrey C Allen; Joshua D Schiffman; David H Gutmann; Joshua B Rubin
Journal:  Cancer Res       Date:  2014-11-07       Impact factor: 12.701

6.  Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects.

Authors:  Karlyne M Reilly; Robert G Tuskan; Emily Christy; Dagan A Loisel; Jeremy Ledger; Roderick T Bronson; C Dahlem Smith; Shirley Tsang; David J Munroe; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-19       Impact factor: 11.205

Review 7.  Grb10 exceeding the boundaries of a common signaling adapter.

Authors:  Heimo Riedel
Journal:  Front Biosci       Date:  2004-01-01

8.  Improved glucose homeostasis and enhanced insulin signalling in Grb14-deficient mice.

Authors:  Gregory J Cooney; Ruth J Lyons; A Jayne Crew; Thomas E Jensen; Juan Carlos Molero; Christopher J Mitchell; Trevor J Biden; Christopher J Ormandy; David E James; Roger J Daly
Journal:  EMBO J       Date:  2004-01-29       Impact factor: 11.598

9.  Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1).

Authors:  J Szudek; H Joe; J M Friedman
Journal:  Genet Epidemiol       Date:  2002-08       Impact factor: 2.135

10.  Disruption of the imprinted Grb10 gene leads to disproportionate overgrowth by an Igf2-independent mechanism.

Authors:  Marika Charalambous; Florentia M Smith; William R Bennett; Tracey E Crew; Francesca Mackenzie; Andrew Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 12.779

View more
  7 in total

1.  Grb7 protein RA domain oligomerization.

Authors:  Malika P Godamudunage; Albert Foster; Darius Warren; Barbara A Lyons
Journal:  J Mol Recognit       Date:  2017-03-14       Impact factor: 2.137

2.  Correction: Monoallelic Loss of the Imprinted Gene Grb10 Promotes Tumor Formation in Irradiated Nf1+/- Mice.

Authors:  Rana Mroue; Brian Huang; Steve Braunstein; Ari J Firestone; Jean L Nakamura
Journal:  PLoS Genet       Date:  2015-06-15       Impact factor: 5.917

3.  ERK Signals: Scaffolding Scaffolds?

Authors:  Berta Casar; Piero Crespo
Journal:  Front Cell Dev Biol       Date:  2016-05-31

4.  Amelioration of Diabetic Mouse Nephropathy by Catalpol Correlates with Down-Regulation of Grb10 Expression and Activation of Insulin-Like Growth Factor 1 / Insulin-Like Growth Factor 1 Receptor Signaling.

Authors:  Shasha Yang; Huacong Deng; Qunzhou Zhang; Jing Xie; Hui Zeng; Xiaolong Jin; Zixi Ling; Qiaoyun Shan; Momo Liu; Yuefei Ma; Juan Tang; Qianping Wei
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

5.  DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma.

Authors:  Serena Ferraresso; Arianna Aricò; Tiziana Sanavia; Silvia Da Ros; Massimo Milan; Luciano Cascione; Stefano Comazzi; Valeria Martini; Mery Giantin; Barbara Di Camillo; Sandro Mazzariol; Diana Giannuzzi; Laura Marconato; Luca Aresu
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

6.  Nf1-Mutant Tumors Undergo Transcriptome and Kinome Remodeling after Inhibition of either mTOR or MEK.

Authors:  Daniela Pucciarelli; Steven P Angus; Benjamin Huang; Chi Zhang; Hiroki J Nakaoka; Ganesh Krishnamurthi; Sourav Bandyopadhyay; D Wade Clapp; Kevin Shannon; Gary L Johnson; Jean L Nakamura
Journal:  Mol Cancer Ther       Date:  2020-08-26       Impact factor: 6.261

7.  Loss of ZIP facilitates JAK2-STAT3 activation in tamoxifen-resistant breast cancer.

Authors:  Ning Zhu; Jing Zhang; Yuping Du; Xiaodong Qin; Ruidong Miao; Jing Nan; Xing Chen; Jingjie Sun; Rui Zhao; Xinxin Zhang; Lei Shi; Xin Li; Yuxi Lin; Wei Wei; Aihong Mao; Zhao Zhang; George R Stark; Yuxin Wang; Jinbo Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-12       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.